Balram, Bhairavi http://orcid.org/0000-0001-6267-9934
Joshi, Harshad
Wong, Karen
Kroeker, Karen I.
Dieleman, Levinus A.
Halloran, Brendan P.
Baumgart, Daniel C.
Peerani, Farhad
Article History
Received: 22 July 2020
Accepted: 30 October 2020
First Online: 13 November 2020
Compliance with Ethical Standards
:
: BB and HJ have no conflicts of interest to disclose. KW has served on the advisory board of Ferring, Pfizer and AbbVie and has served on the speaker's bureau for AbbVie. KIK has received consulting fees from AbbVie, Janssen, Takeda and Ferring and has served on the speaker’s bureau for AbbVie and Janssen. LD has received consulting fees from AbbVie and Janssen and has served on the speaker’s bureau for AbbVie and Janssen. BPH has received consulting fees from AbbVie and Janssen and has served on the speaker’s bureau for AbbVie, Janssen, Shire and Pendopharm. DB has served over the past 15 years on external scientific advisory boards for 4d Pharma, Abbott, AbbVie, Allergan, Amgen, Astra Zeneca, Bayer, Biogen, Boehringer Ingelheim, Bristol-Myers Squibb (BMS), Celgene, Cellerix, Centocor, CSL Behring, Dr. Falk, Elan, Eli Lilly, Ferring, Forward, Genentech, Gilead, Glaxo Smith Kline (GSK), Hitachi, Janssen, Johnson & Johnson, Merck, Merck Serono, Merck Sharp Dohme (MSD), Millenium, Novartis, Novo Nordisk, Ocera, Otsuka, PDL Biopharma, Pfizer, Prometheus, Recordati, Roche, Sandoz, Sanofi Aventis, Schering, Schering-Plough, Shield, Shire, Takeda, Theravance, TiGenix, Tilliotts Pharma AG, UCB Pharma and Vifor. All of his activities and contracts are in conformity with the “FSA-Kodex Fachkreise” (voluntary self-monitoring code for expert consultants to the pharmaceutical industry) and they have been checked and approved by the Faculty of Medicine. FP has received consulting fees from AbbVie, Janssen, Ferring, Takeda, Pfizer and Pharmascience and has served on the speaker’s bureau for AbbVie, Janssen, Takeda and Pfizer.